Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 85 years. Other eligibility criteria apply.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 32
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 85 Years
- Official registry ID
- NCT00955474
- Official title
Show the full official title
The Efficacy and Tolerability of Seroquel XR Combined With a Selective Serotonin Re-Uptake Inhibitor Versus Seroquel XR Monotherapy in the Acute Treatment of Major Depressive Disorder With Psychotic Features
Recruitment & locations
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Quetiapine, escitalopram, Sertraline and Citalopram.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 85 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
